Clinical Trials Directory

Trials / Completed

CompletedNCT01692847

Examination of the Impact of Better Surveillance and Communication of Patient Deterioration on Patient Related Outcomes

Examination of the Impact of Better Surveillance and Communication of Patient Deterioration on Patient Related Outcomes (VitalCare - Guardian Version 2)

Status
Completed
Phase
Study type
Observational
Enrollment
678 (actual)
Sponsor
Philips Healthcare · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A hospitals manual method of patient monitoring will be implemented in an automated system and supported by an early patient deterioration detection for timely escalation. The purpose of this study is to assess if clinical outcomes of patients in Acute Care are significantly improved by such a system.

Detailed description

The purpose of this study is to assess if the Philips IntelliVue Guardian Solution (IGS) with all its components can significantly improve clinical outcomes for deteriorating patients on a general medical ward prior and after referral to the hospitals' Acute Care Team (ACT). Further, to provide evidence that the Philips IGS assists to increase the efficiency of a hospital's Early Warning Scoring process (afferent and efferent arm of the escalation system). The introduction of such an intelligent automated system offers a unique opportunity to address the breakdown in the chain of prevention by strengthening the reliability of calls-for-help to responders through a technical solution with the potential for a more timely escalation where appropriate. In this study the hospital's Standard of Care protocol for the monitoring of vital signs (including timing, vital signs collected and escalation instructions) will be implemented in a commercially available intelligent automatic monitoring and notification system. No investigational procedures or devices are associated with this protocol.

Conditions

Timeline

Start date
2012-10-01
Primary completion
2016-02-01
Completion
2016-02-01
First posted
2012-09-25
Last updated
2016-04-04

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01692847. Inclusion in this directory is not an endorsement.